Evidence map›Paper›PMID 31061927›Full record

ArticleJACC. Basic to translational science2019

Deletion of Sulfonylurea Receptor 2 in the Adult Myocardium Enhances Cardiac Glucose Uptake and Is Cardioprotective.

Gregory Aubert, David Y Barefield, Alexis R Demonbreun, Mohun Ramratnam, Katherine S Fallon, James L Warner, Ann E Rossi, Michele Hadhazy, Jonathan C Makielski, Elizabeth M McNally

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Gregory AubertCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
David Y BarefieldCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
Alexis R DemonbreunCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
Mohun RamratnamDivision of Cardiology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
Katherine S FallonCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
James L WarnerCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
Ann E RossiSection of Cardiology, University of Chicago, Chicago Illinois.
Michele HadhazyCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago Illinois.
Jonathan C MakielskiDivision of Cardiology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
Elizabeth M McNallySection of Cardiology, University of Chicago, Chicago Illinois.
Northwestern University · USUniversity of Wisconsin–Madison · USUniversity of Chicago · USUniversity of Illinois Chicago · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Mechanisms of sulfonylurea receptor mediated cardiomyopathyR01HL122109 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MAKIELSKI, JONATHAN C, MCNALLY, ELIZABETH M · 2015 to 2018
$2.4M
Myofilament proteins in cardiomyopathy and arrhythmiasK99HL141698 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BAREFIELD, DAVID Y · 2019 to 2020
$196k
Myosin binding protein H-like and its role in cardiomyopathyF32HL131304 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BAREFIELD, DAVID Y · 2016 to 2018
$155k
NCATS NIH HHS UL1 TR001422NHLBI NIH HHS F32 HL131304NHLBI NIH HHS K99 HL141698NHLBI NIH HHS R01 HL122109
6 · The paper itself

Abstract

The adult myocardium relies on oxidative metabolism. In ischemic myocardium, such as the embryonic heart, glycolysis contributes more prominently as a fuel source. The sulfonylurea receptor 2 (SUR2) was previously implicated in the normal myocardial transition from glycolytic to oxidative metabolism that occurs during adaptation to postnatal life. This receptor was now selectively deleted in adult mouse myocardium resulting in protection from ischemia reperfusion injury. SUR2-deleted cardiomyocytes had enhanced glucose uptake, and SUR2 forms a complex with the major glucose transporter. These data identify the SUR2 receptor as a target to shift cardiac metabolism to protect against myocardial injury.

Indexed as

2DG, 2-deoxy-D-glucoseABCC9EDTA, ethylenediaminetetraacetic acidFL Ex5, LoxP sites flanking exon 5GFP, green fluorescent proteinGLUT, glucose transporterHEK293T, human embryonic kidney 293TischemiaKATP, adenosine triphosphate–sensitive potassiumKir, inward rectifying potassium channelLVDP, left ventricular developed pressureMCM, αMHC-MerCreMerPCR, polymerase chain reactionpotassium ATP channelssulfonylureaSUR, sulfonylurea receptor

Identifiers

PMID31061927
PMCPMC6488756
OpenAlexW2942913172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.